Area of research
Oncology · Cancer Research
Research interest
Research interests include Breast Cancer Treatment Studies, Global Cancer Incidence and Screening, BRCA gene mutations in cancer, and Cancer Risks and Factors.
Genome-wide association study of Asian women identifies putative mammographic density-associated loci
The Lancet Breast Cancer Commission
Global Cancer Surgery: pragmatic solutions to improve cancer surgery outcomes worldwide
Feasibility of monitoring Global Breast Cancer Initiative Framework key performance indicators in 21 Asian National Cancer Centers Alliance member countries
Achieving global surgical excellence: an evidence-based framework to guide surgical quality improvement programs in low and middle income countries
Pathology of Tumors Associated With Pathogenic Germline Variants in 9 Breast Cancer Susceptibility Genes
Predicting the Likelihood of Carrying a <i>BRCA1</i> or <i>BRCA2</i> Mutation in Asian Patients With Breast Cancer
Polygenic risk scores for prediction of breast cancer risk in Asian populations
Germline <scp> <i>APOBEC3B</i> </scp> deletion increases somatic hypermutation in Asian breast cancer that is associated with Her2 subtype, <scp> <i>PIK3CA</i> </scp> mutations and immune activation
Breast cancer early detection: A phased approach to implementation
European polygenic risk score for prediction of breast cancer shows similar performance in Asian women
The Breast Health Global Initiative 2018 Global Summit on Improving Breast Healthcare Through Resource‐Stratified Phased Implementation: Methods and overview
Epidemiological and ES cell‐based functional evaluation of <i>BRCA2</i> variants identified in families with breast cancer
Cancer Risks Associated With Germline<i>PALB2</i>Pathogenic Variants: An International Study of 524 Families
Reproductive profiles and risk of breast cancer subtypes: a multi-center case-only study
Inherited mutations in <i>BRCA1</i> and <i>BRCA2</i> in an unselected multiethnic cohort of Asian patients with breast cancer and healthy controls from Malaysia
A Standard Set of Value-Based Patient-Centered Outcomes for Breast Cancer
Breast cancer risk variants at 6q25 display different phenotype associations and regulate ESR1, RMND1 and CCDC170
Evidence that the 5p12 Variant rs10941679 Confers Susceptibility to Estrogen-Receptor-Positive Breast Cancer through FGF10 and MRPS30 Regulation
Prediction of breast cancer risk based on common genetic variants in women of East Asian ancestry
The Predictive Accuracy of PREDICT
Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with prognosis of estrogen receptor-negative breast cancer after chemotherapy
FGF receptor genes and breast cancer susceptibility: results from the Breast Cancer Association Consortium
2q36.3 is associated with prognosis for oestrogen receptor-negative breast cancer patients treated with chemotherapy
Supportive care after curative treatment for breast cancer (survivorship care): Resource allocations in low- and middle-income countries. A Breast Health Global Initiative 2013 consensus statement
Common genetic determinants of breast-cancer risk in East Asian women: a collaborative study of 23 637 breast cancer cases and 25 579 controls
Breast cancer research in Asia: Adopt or adapt Western knowledge?
Ethnic Differences in Survival after Breast Cancer in South East Asia